235 related articles for article (PubMed ID: 35317841)
1. A non-coding RNA balancing act: miR-346-induced DNA damage is limited by the long non-coding RNA NORAD in prostate cancer.
Fletcher CE; Deng L; Orafidiya F; Yuan W; Lorentzen MPGS; Cyran OW; Varela-Carver A; Constantin TA; Leach DA; Dobbs FM; Figueiredo I; Gurel B; Parkes E; Bogdan D; Pereira RR; Zhao SG; Neeb A; Issa F; Hester J; Kudo H; Liu Y; Philippou Y; Bristow R; Knudsen K; Bryant RJ; Feng FY; Reed SH; Mills IG; de Bono J; Bevan CL
Mol Cancer; 2022 Mar; 21(1):82. PubMed ID: 35317841
[TBL] [Abstract][Full Text] [Related]
2. Radiation induces NORAD expression to promote ESCC radiotherapy resistance via EEPD1/ATR/Chk1 signalling and by inhibiting pri-miR-199a1 processing and the exosomal transfer of miR-199a-5p.
Sun Y; Wang J; Ma Y; Li J; Sun X; Zhao X; Shi X; Hu Y; Qu F; Zhang X
J Exp Clin Cancer Res; 2021 Sep; 40(1):306. PubMed ID: 34587992
[TBL] [Abstract][Full Text] [Related]
3. The long noncoding RNA noncoding RNA activated by DNA damage (NORAD)-microRNA-496-Interleukin-33 axis affects carcinoma-associated fibroblasts-mediated gastric cancer development.
Huang C; Liu J; He L; Wang F; Xiong B; Li Y; Yang X
Bioengineered; 2021 Dec; 12(2):11738-11755. PubMed ID: 34895039
[TBL] [Abstract][Full Text] [Related]
4. Long non-coding RNA NORAD promotes the prostate cancer cell extracellular vesicle release via microRNA-541-3p-regulated PKM2 to induce bone metastasis of prostate cancer.
Hu CY; Chen J; Qin XH; You P; Ma J; Zhang J; Zhang H; Xu JD
J Exp Clin Cancer Res; 2021 Mar; 40(1):98. PubMed ID: 33722248
[TBL] [Abstract][Full Text] [Related]
5. Long non-coding RNA-non-coding RNA activated by DNA damage inhibition suppresses hepatic stellate cell activation via microRNA-495-3p/sphingosine 1-phosphate receptor 3 axis.
Zou L; Shi C; Wang D; Cheng J; Wang Q; Wang L; Yang G
Bioengineered; 2022 Mar; 13(3):6150-6162. PubMed ID: 35200103
[TBL] [Abstract][Full Text] [Related]
6. The NORAD lncRNA assembles a topoisomerase complex critical for genome stability.
Munschauer M; Nguyen CT; Sirokman K; Hartigan CR; Hogstrom L; Engreitz JM; Ulirsch JC; Fulco CP; Subramanian V; Chen J; Schenone M; Guttman M; Carr SA; Lander ES
Nature; 2018 Sep; 561(7721):132-136. PubMed ID: 30150775
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA NORAD/miR-224-3p/MTDH axis contributes to CDDP resistance of esophageal squamous cell carcinoma by promoting nuclear accumulation of β-catenin.
Jia Y; Tian C; Wang H; Yu F; Lv W; Duan Y; Cheng Z; Wang X; Wang Y; Liu T; Wang J; Liu L
Mol Cancer; 2021 Dec; 20(1):162. PubMed ID: 34893064
[TBL] [Abstract][Full Text] [Related]
8. Long non-coding RNA NORAD promotes pancreatic cancer stem cell proliferation and self-renewal by blocking microRNA-202-5p-mediated ANP32E inhibition.
Ma YS; Yang XL; Liu YS; Ding H; Wu JJ; Shi Y; Jia CY; Lu GX; Zhang DD; Wang HM; Wang PY; Yu F; Lv ZW; Wang GR; Liu JB; Fu D
J Transl Med; 2021 Sep; 19(1):400. PubMed ID: 34551785
[TBL] [Abstract][Full Text] [Related]
9. Long non-coding RNA NORAD contributes to the proliferation, invasion and EMT progression of prostate cancer via the miR-30a-5p/RAB11A/WNT/β-catenin pathway.
Zhang Y; Li Y
Cancer Cell Int; 2020 Nov; 20(1):571. PubMed ID: 33292272
[TBL] [Abstract][Full Text] [Related]
10. Long non-coding RNA NORAD protects against cerebral ischemia/reperfusion injury induced brain damage, cell apoptosis, oxidative stress and inflammation by regulating miR-30a-5p/YWHAG.
Zhou X; Wang Z; Xu B; Ji N; Meng P; Gu L; Li Y
Bioengineered; 2021 Dec; 12(2):9174-9188. PubMed ID: 34709972
[TBL] [Abstract][Full Text] [Related]
11. LncRNA NORAD Mediates the Proliferation and Apoptosis of Diffuse Large-B-Cell Lymphoma via Regulation of miR-345-3p/TRAF6 Axis.
Li Y; Lv Y; Wang J; Zhu X; Chen J; Zhang W; Wang C; Jiang L
Arch Med Res; 2022 Apr; 53(3):271-279. PubMed ID: 35164979
[TBL] [Abstract][Full Text] [Related]
12. Long non‑coding RNA NORAD regulates angiogenesis of human umbilical vein endothelial cells via miR‑590‑3p under hypoxic conditions.
Zhao X; Wei X; Wang X; Qi G
Mol Med Rep; 2020 Jun; 21(6):2560-2570. PubMed ID: 32323787
[TBL] [Abstract][Full Text] [Related]
13. Silenced long non-coding RNA activated by DNA damage elevates microRNA-495-3p to suppress atherosclerotic plaque formation via reducing Krüppel-like factor 5.
Fu DN; Wang Y; Yu LJ; Liu MJ; Zhen D
Exp Cell Res; 2021 Apr; 401(2):112519. PubMed ID: 33636159
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA NORAD promotes the occurrence and development of non-small cell lung cancer by adsorbing MiR-656-3p.
Chen T; Qin S; Gu Y; Pan H; Bian D
Mol Genet Genomic Med; 2019 Aug; 7(8):e757. PubMed ID: 31207175
[TBL] [Abstract][Full Text] [Related]
15. LncRNA NORAD promotes proliferation, migration and angiogenesis of hepatocellular carcinoma cells through targeting miR-211-5p/FOXD1/VEGF-A axis.
Sun DS; Guan CH; Wang WN; Hu ZT; Zhao YQ; Jiang XM
Microvasc Res; 2021 Mar; 134():104120. PubMed ID: 33309645
[TBL] [Abstract][Full Text] [Related]
16. Long non-coding RNA NORAD induces phenotypic regulation of vascular smooth muscle cells through regulating microRNA-136-5p-targeted KDM1A.
Lv C; Wang J; Dai S; Chen Y; Jiang X; Li X
Cell Cycle; 2021 Oct; 20(20):2137-2148. PubMed ID: 34583619
[TBL] [Abstract][Full Text] [Related]
17. Long noncoding RNA NORAD acts as a ceRNA mediates gemcitabine resistance in bladder cancer by sponging miR-155-5p to regulate WEE1 expression.
Yang Y; Zhang G; Li J; Gong R; Wang Y; Qin Y; Ping Q; Hu L
Pathol Res Pract; 2021 Dec; 228():153676. PubMed ID: 34753061
[TBL] [Abstract][Full Text] [Related]
18. Long noncoding RNA NORAD is upregulated in epithelial ovarian cancer and its downregulation suppressed cancer cell functions by competing with miR-155-5p.
Tong L; Ao Y; Zhang H; Wang K; Wang Y; Ma Q
Cancer Med; 2019 Aug; 8(10):4782-4791. PubMed ID: 31250987
[TBL] [Abstract][Full Text] [Related]
19. LncRNA NORAD accelerates the progression and doxorubicin resistance of neuroblastoma through up-regulating HDAC8 via sponging miR-144-3p.
Wang B; Xu L; Zhang J; Cheng X; Xu Q; Wang J; Mao F
Biomed Pharmacother; 2020 Sep; 129():110268. PubMed ID: 32563146
[TBL] [Abstract][Full Text] [Related]
20. LncRNA NORAD regulates scar hypertrophy via miRNA-26a mediating the regulation of TGFβR1/2.
Qi J; Wu Y; Zhang H; Liu Y
Adv Clin Exp Med; 2021 Apr; 30(4):395-403. PubMed ID: 33857357
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
